Atossa Therapeutics Inc. (ATOS)
Atossa Therapeutics Statistics
Share Statistics
Atossa Therapeutics has 129.17M shares outstanding. The number of shares has increased by 2.71% in one year.
| Shares Outstanding | 129.17M |
| Shares Change (YoY) | 2.71% |
| Shares Change (QoQ) | 2.68% |
| Owned by Institutions (%) | 23.8% |
| Shares Floating | 129.11M |
| Failed to Deliver (FTD) Shares | 11.86K |
| FTD / Avg. Volume | 1.85% |
Short Selling Information
The latest short interest is 8.1M, so 6.27% of the outstanding shares have been sold short.
| Short Interest | 8.1M |
| Short % of Shares Out | 6.27% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 15.02 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -2.15. Atossa Therapeutics's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -2.15 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Atossa Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.99, with a Debt / Equity ratio of 0.
| Current Ratio | 14.99 |
| Quick Ratio | 14.99 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-2.01M |
| Employee Count | 15 |
| Asset Turnover | null |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -56.34% in the last 52 weeks. The beta is 1.47, so Atossa Therapeutics's price volatility has been higher than the market average.
| Beta | 1.47 |
| 52-Week Price Change | -56.34% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 43.08 |
| Average Volume (20 Days) | 642.58K |
Income Statement
| Revenue | n/a |
| Gross Profit | -23K |
| Operating Income | -31.38M |
| Net Income | -30.09M |
| EBITDA | -31.35M |
| EBIT | -31.38M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 71.08M in cash and 0 in debt, giving a net cash position of 71.08M.
| Cash & Cash Equivalents | 71.08M |
| Total Debt | 0 |
| Net Cash | 71.08M |
| Retained Earnings | -211.79M |
| Total Assets | 76.44M |
| Working Capital | 69.49M |
Cash Flow
In the last 12 months, operating cash flow was -21.03M and capital expenditures -19K, giving a free cash flow of -21.05M.
| Operating Cash Flow | -21.03M |
| Capital Expenditures | -19K |
| Free Cash Flow | -21.05M |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ATOS is $7, which is 1029% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 1029% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Apr 20, 2018. It was a backward split with a ratio of 1:12.
| Last Split Date | Apr 20, 2018 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | 5.92 |
| Piotroski F-Score | 1 |